L Alvarez 2018 Adjuncts to Steroid Treatment

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Atrial Fibrillation Cardiovascular ISCEE 26th October 2010.
New Atrial Fibrillation/Flutter Pathway and GRASP Tool
New Atrial Fibrillation/Flutter Pathway and GRASP Tool
A Management Algorithm for Temporal Arteritis How Not to Miss this Blinding Disease Duncan P. Anderson, MD University of British Columbia Division of Neuro-Ophthalmology.
Anterior ischemic optic neuropathy (AION) Most common over 50 years Painless monocular over hours to days Visual acuity Visual field APD.
Specific Symptoms Central vision………….A macula B cornea Knife like pain…………A iritis b neuralgia Jaw pain/headache … A Giant Cell arteritis B corneal ulcer.
Management of Stroke and Transient Ischaemic Attack Sam Thomson.
Stroke Mark Sudlow Consultant and Senior Lecturer
Polymyalgia Rheumatica and Giant Cell Arteritis
Lananh Nguyen, M.D. Division of Neuropathology University of Pittsburgh Medical Center 72-year-old male with fever of unknown origin.
Polymyalgia Rheumatica (PMR) Temporal Arteritis (TA)
DR DIPTI CHITNAVIS HAEMATOLOGY CONSULTANT WEST SUFFOLK HOSPITAL JANUARY 2014 Update on the new oral anticoagulants; 12 months on.
UBC Ophthalmology Interest Group Seminar Series
VISUAL LOSS IN THE ELDERLY
Leo Semes, OD Professor, Optometry UAB, Birmingham, AL.
History of PMR 1888 First described as senile rheumatic gout (Bruce) 1936Secondary fibrositis 1945Periarthrosis humeroscapular 1946Peri-extra-articular.
5) Migraine Throbbing pain lasting hours - 3 days Sensitivity to stimuli: light and sound, sometimes smells Nausea Aggravated by physical activity (prefers.
PMR & GCA Janet Pope Professor of Medicine Division of Rheumatology University of Western Ontario Polymyalgia Rheumatica (PMR) Giant-Cell Arteritis (GCA)
 70yo woman presents with sudden onset loss of vision in her right eye half hour ago  No improvement since  No previous ophthalmic history  What are.
PAD, AAA Wu Chean 3/3/14. Q1: You are the FY1 in A&E Referral from GP: Thank you for seeing this 65 y.o. male with a painful foot and worsening gangrenous.
Giant cell arteritis and Polymyalgia rheumatica
Consultant Neurologist,
GIANT CELL ARTERITIS (Temporal or Cranial Arteritis)
Polymyalgia Rheumatica A micro-teach of BSR & BHPR guidelines
Ocular Ischaemic Syndrome Dr Gulrez Ansari Department of Ophthalmology Watford General Hospital 3 rd November 2004.
Giant Cell Arteritis Julie Story July 27, Overview Typical case presentation Differential diagnosis Confirming the diagnosis Associated symptoms.
OPTIC NEUROPATHIES 1. Clinical features 2. Special investigations
THE ROLE OF PLATELET COUNT IN DECISION-MAKING FOR SUSPECTED GIANT CELL ARTERITIS CS Bouchard, MD, AZ Ahmad, MD, WC Park, MD, B Hayek, MD, S Blatt, MS4.
Acute Coronary Syndromes in West Hertfordshire Masood Khan.
Tubulointerstitial Nephritis and Uveitis (TINU) Syndrome Sana Khochtali Imen Ksiaa Anis Mahmoud Bechir Jelliti Department of Ophthalmology Fattouma Bourguiba.
Choroidal Tuberculoma Rupesh Agrawal, Carlos Pavesio Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
Acute Painless Loss of Vision
Warfarin PSD/HOF001/GB/DC/Rev013 Issued : Review interval:12 months This document may be reviewed and reissued electronically without notice.
DIABETES & VASCULAR FOOT REFERRAL GUIDANCE 2013 Ver4.0 With keys points adapted from NICE Guidelines - The Prevention and Management of Foot Problems in.
Mark McCracken Clinical Governance & Performance Lead (PEATS) Primary Eye Care (Shropshire & Staffordshire) Ltd.
Fast track diagnosis and management of GCA
The Eye The eye is often compared to a camera. Light comes in through the cornea, pupil, and lens in front of the eye just as the lens of the camera.
Fever in childhood. Introduction Commonest reason for admission to hospital in UK Either alone or with associated symptoms Self limiting or life threatening.
Acute Painless Loss of Vision
Acute visual loss: Emergency room perspective
HIV acutely unwell pathway Sussex HIV Network This pathway applies to all patients other than those listed in non-acute pathway All HIV+ patients with.
Cranial nerve.
Quality of Referrals Guideline Congruence of referrals to TIAMS clinic
A&E MANAGEMENT OF NON- TRAUMATIC ACUTE LOW BACK PAIN
OPTIC NEUROPATHIES 1. Clinical features 2. Special investigations
Ian Simmons Leeds Teaching Hospitals NHS Trust
Primary-Secondary Care Partnership in Treatment of Severe Cellulitis
Northern East Adult Headache Management Guideline
Rheumatology for the GP
Central Retinal Artery Occlusion
Six stage journey When diagnosed with a brain tumour.
Cornwall & IoS Diabetic foot check & referral pathway Dec 2017
Fibrillazione atriale
West Essex Frailty Pathway: UTI
Sepsis Dr Helen Dillon June 2017.
West Essex Frailty Pathway: Heart Failure
DUDLEY DRY EYE PATHWAY Diagnosed Dry Eye Patient Self care
West Essex Frailty Pathway: COPD
OPHTHALMOLOGY REFERRAL PATHWAY FOR N. IRELAND
Dr. abdulrhman alsugihi Consultant ophthalmologist
Calculate Well’s score for PE (BOX1)
Polymyalgia and Giant Cell Arteritis
Neuroretinitis Rupesh Agrawal, Carlos Pavesio Moorfields Eye Hospital,
DUDLEY DRY EYE PATHWAY Diagnosed Dry Eye Patient Self care
ED Consultant (Imperial)
Important notes by the doctor
MODERATE Risk 1 RISK FACTOR PRESENT Deformity OR Neuropathy OR Peripheral arterial disease No other risk factors x6 more likely to ulcerate Annual assessment.
Hypertensive Crisis Halmat M. Jaafar (MSc. Clinical pharmacy)
Presentation transcript:

L Alvarez 2018 Adjuncts to Steroid Treatment Choroidal ischemia/ perfusion delay behind transient or other visual loss without infarcted disc in GCA Arteritic disc : acute pale swelling with (usually if temporal disc involved) very poor vision (+++ suggestive) Suspected Giant Cell Arteritis (GCA) presenting to the BMEC Accident and Emergency Suspect Acute ocular ARTERIAL ischemic signs ( ischemic optic neuropathy, retinal ischemia, amaurosis fugax/ transient visual loss) new onset non explained visual disturbance or diplopia in patient > 50. (* note GCA is very rare in non-caucasians, but not impossible). Typical Systemic Symptoms? (can be absent [20%]) Scalp pain or tenderness Jaw claudication Limb claudication Hip/shoulder girdle pain and stiffness Lethargy, malaise, fever, weight loss, Supportive Examination? Thickened, tender or non-pulsatile TAs Cranial nerve / compatible visual signs/ symptom Peripheral pulses – inequality/absence/bruits High Acute Phase Response? Urgent FBC, U&E, LFT, ESR, CRP, Glu, INR, (HbA1c) Pre-test probability : GCA still suspected? High suspicion : Raised inflammatory markers + systemic signs, compatible or patognomonic ocular presentation (arteritic AION) High suspicion Low suspicion Intermediate suspicion Raised inflammatory markers, absent or few systemic symptoms, compatible / possible ocular presentation Consider alternative cause eg if amaurosis fugax = TIA? Embolic source  urgent referral stroke pathway No visual symptoms (eg GP referral with very suggestive systemic symptoms), raised inflammatory markers Impending (acute visual symptoms) or established visual loss Consider risk/benefit of high dose steroids and probability of pre-test diagnosis before commencing steroids Consider urgent admission (if visual loss/ visual symptoms) for IV steroids Organise TAB Medical assessment/ Fill out referral leaflet Urgent referral to neuro-ophthalmology Commence FIRST dose of steroids (oral 40-60 MG OD) Organise TAB/ Doppler TA Medical assessment/ Fill out referral leaflet Urgent referral to rheumatology Admit and commence FIRST dose of steroids STAT * and organise temporal artery biopsy (TAB) Medical assessment/ Fill out referral leaflet Start AAS if no contraindication Referral to rheumatology/ neuro-ophthalmology STEROIDS and High suspicion GCA * Some evidence supports IV versus oral steroids in GCA with acute visual loss, in GCA but if delays are expected/ unavoidable for intravenous administration, start oral stat in the Accident and Emergency department. Assess risk/ benefit of oral versus IV (oral may be preferable in CKD/ electrolite imbalance/ cardiac failure/ diabetes) In high suspicion GCA, first dose of steroids must not be delayed. Chest X ray should be organised acutely on starting steroids but never delaying first dose. Dose of intravenous steroids : 15 mg/kg BW Methylprednisolone (up to 1g per day) for 3 days when acute visual loss / impending visual loss. Alternative: 60 mg oral prednisolone Steroids for treatment of GCA are maintained (always under rheumatology guidance) 40mg or 60mg for 4 weeks - or longer until symptoms resolved- then reduce dose by 10mg every 2 weeks until 20mg, then reduce dose by 2.5mg every 2 weeks until 10mg, then reduce dose by 0.5-1mg every 2 months Adjuncts to Steroid Treatment Prednisolone oral tablets – non-enteric coated – dose as per pathway Aspirin 75mg OD to prevent (further) neuro-ophthalmic complications Proton pump inhibitor (PPI) or H2 antagonist for gastroprotection Calcium and vitamin D supplement and Bisphosphonate (if no contraindication – consider renal function, previous peptic ulcer disease etc.) Medical assessment Always document full medical history : cardiac or renal failure, diabetes, other systemic comorbidities? If present : medical review by medical team (rheumatology) as inpatient, consider adjusting dose of steroids

Sandwell and West Birmingham NHS Trust Suspected Giant Cell Arteritis (GCA) Care Pathway - Referral form – draft 1 Surname: Forename: Location of Patient: Eye casualty............................ Date of Birth: Ward....................................... GP practice............................. Hospital (RXK) or NHS no: Patient Tel.number:......................................... Symptoms: (circle yes / no) Investigations: Scalp pain or tenderness yes / no ESR (mm/h)............................ Jaw claudication yes / no Visual loss or blurring, diplopia yes / no CRP (mg/L)............................. Hip/shoulder girdle pain or stiffness yes / no Lethargy, malaise, anorexia, weight loss yes / no GFR ml/min2........................... Fever yes / no Limb claudication yes / no Plts x109/L........................... Signs: (circle as appropriate) INR……………………………………… Temporal artery / branches tender No – R – L – Both Temporal artery / branches thickened No – R – L – Both Temporal pulses absent No – R – L – Both Description of visual symptoms and signs Amaurosis fugax / Ischemic optic neuropathy/ Other (specify ) R – L – Both …………………………………………………………………………………………………………………………………………………………… Comorbidities: (circle) Diabetes Osteoporosis CKD Ischaemic heart disease other (please state).................................................................................................................... Drug Treatment (circle) Aspirin Warfarin/Rivaroxaban/Clexane etc. Bisphosphonate PPI or H2 antagonist Calcium/vitamin D other (please state)..................................................................................................................... ACTION BY REFERRER: Dose of Prednisolone commenced?.............................. Date: ...../...../..... TA Ultrasound (US skull on iCM) scheduled? yes/no Date: ...../...../..... Print Name:........................................................................... Contact tel./bleep..................... Signature:.............................................................................. Date: ...../...../..... FAX REFERRAL TO 0121 507 5451 (City) OR 0121 507 3696 (Sandwell) PLEASE CALL 0121 507 5793 (City) OR 0121 507 3470 (Sandwell) TO CONFIRM RECEIPT Contact Rheumatology SpR at City / Sandwell Hospital or Consultant on-call via Switch if queries